Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Quantification of mitochondrial toxicity in HIV-infected individuals by quantitative PCR compared to flow cytometry.

Wagner TA, Lin CH, Tobin NH, Côté HC, Sloan DD, Jerome KR, Frenkel LM.

Cytometry B Clin Cytom. 2013 Jan-Feb;84(1):55-8. doi: 10.1002/cyto.b.21045. Epub 2012 Oct 8.

2.

Mitochondrial evolution in HIV-infected children receiving first- or second-generation nucleoside analogues.

Morén C, Noguera-Julian A, Garrabou G, Catalán M, Rovira N, Tobías E, Cardellach F, Miró Ò, Fortuny C.

J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):111-6. doi: 10.1097/QAI.0b013e318250455e.

PMID:
22362155
3.

The influence of HIV infection and antiretroviral therapy on the mitochondrial membrane potential of peripheral mononuclear cells.

Sternfeld T, Schmid M, Tischleder A, Mudra S, Schlamp A, Kost BP, Gruber R, Youle M, Bogner JR, Goebel FD.

Antivir Ther. 2007;12(5):769-78.

PMID:
17713160
4.

Peripheral blood mitochondrial DNA/nuclear DNA (mtDNA/nDNA) ratio as a marker of mitochondrial toxicities of stavudine containing antiretroviral therapy in HIV-infected Malawian patients.

Kampira E, Dzobo K, Kumwenda J, van Oosterhout JJ, Parker MI, Dandara C.

OMICS. 2014 Jul;18(7):438-45. doi: 10.1089/omi.2014.0026. Epub 2014 May 9.

PMID:
24816082
5.

Prevalence of lipoatrophy and mitochondrial DNA content of blood and subcutaneous fat in HIV-1-infected patients randomly allocated to zidovudine- or stavudine-based therapy.

van der Valk M, Casula M, Weverlingz GJ, van Kuijk K, van Eck-Smit B, Hulsebosch HJ, Nieuwkerk P, van Eeden A, Brinkman K, Lange J, de Ronde A, Reiss P.

Antivir Ther. 2004 Jun;9(3):385-93.

PMID:
15259901
6.

Assessment of mitochondrial toxicity by analysis of mitochondrial protein expression in mononuclear cells.

Lin CH, Sloan DD, Dang CH, Wagner T, Cabrera AJ, Tobin NH, Frenkel LM, Jerome KR.

Cytometry B Clin Cytom. 2009 May;76(3):181-90. doi: 10.1002/cyto.b.20458.

7.

Mitochondrial effects of antiretroviral therapies in asymptomatic patients.

López S, Miró O, Martínez E, Pedrol E, Rodríguez-Santiago B, Milinkovic A, Soler A, García-Viejo MA, Nunes V, Casademont J, Gatell JM, Cardellach F.

Antivir Ther. 2004 Feb;9(1):47-55.

PMID:
15040536
8.

Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naïve patients.

Maagaard A, Holberg-Petersen M, Kvittingen EA, Sandvik L, Bruun JN.

HIV Med. 2006 Jan;7(1):53-8.

9.

[Fatal lactic acidosis in a patient infected by HIV and treated with stavudine and didanosine].

Mégarbane B, Goldgran-Tolédano D, Guérin JM, Baud F.

Pathol Biol (Paris). 2000 Jun;48(5):505-7. French.

PMID:
10949849
10.
11.

Common inherited mitochondrial DNA mutations and nucleoside reverse transcriptase inhibitor-induced severe hyperlactataemia in HIV-infected adults: an exploratory study.

Arenas-Pinto A, Weller I, Ekong R, Grant A, Karstaedt A, Reiss P, Telisinghe L, Weber R, Bolhaar M, Bradman N, Ingram C.

Antivir Ther. 2012;17(2):275-82. doi: 10.3851/IMP1947. Epub 2011 Nov 7. Erratum in: Antivir Ther. 2012;17(6):1103-4.

PMID:
22293466
12.

Plasma Mitochondrial DNA Levels as a Biomarker of Lipodystrophy Among HIV-infected Patients Treated with Highly Active Antiretroviral Therapy (HAART).

Dai Z, Cai W, Hu F, Lan Y, Li L, Chung C, Caughey B, Zhang K, Tang X.

Curr Mol Med. 2015;15(10):975-9.

PMID:
26592244
13.

Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV-positive HAART recipients.

Pace CS, Martin AM, Hammond EL, Mamotte CD, Nolan DA, Mallal SA.

Antivir Ther. 2003 Aug;8(4):323-31.

PMID:
14518702
14.

Mitochondrial disruption and apoptosis in lymphocytes of an HIV infected patient affected by lactic acidosis after treatment with highly active antiretroviral therapy.

Tolomeo M, Mancuso S, Todaro M, Stassi G, Catalano M, Arista S, Cannizzo G, Barbusca E, Abbadessa V.

J Clin Pathol. 2003 Feb;56(2):147-51.

15.

Upregulatory mechanisms compensate for mitochondrial DNA depletion in asymptomatic individuals receiving stavudine plus didanosine.

Miró O, López S, Rodríguez de la Concepción M, Martínez E, Pedrol E, Garrabou G, Giralt M, Cardellach F, Gatell JM, Vilarroya F, Casademont J.

J Acquir Immune Defic Syndr. 2004 Dec 15;37(5):1550-5.

PMID:
15577406
16.

Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients.

Côté HC, Brumme ZL, Craib KJ, Alexander CS, Wynhoven B, Ting L, Wong H, Harris M, Harrigan PR, O'Shaughnessy MV, Montaner JS.

N Engl J Med. 2002 Mar 14;346(11):811-20.

17.

Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy.

Shikuma CM, Hu N, Milne C, Yost F, Waslien C, Shimizu S, Shiramizu B.

AIDS. 2001 Sep 28;15(14):1801-9.

PMID:
11579242
18.

Mitochondrial assessment in asymptomatic HIV-infected paediatric patients on HAART.

Morén C, Noguera-Julian A, Rovira N, Garrabou G, Nicolàs M, Cardellach F, Martínez E, Sánchez E, Miró O, Fortuny C.

Antivir Ther. 2011;16(5):719-24. doi: 10.3851/IMP1806.

PMID:
21817193
19.

Mitochondrial DNA depletion and respiratory chain enzyme deficiencies are present in peripheral blood mononuclear cells of HIV-infected patients with HAART-related lipodystrophy.

Miró O, López S, Pedrol E, Rodríguez-Santiago B, Martínez E, Soler A, Milinkovic A, Casademont J, Nunes V, Gatell JM, Cardellach F.

Antivir Ther. 2003 Aug;8(4):333-8.

PMID:
14526764
20.

Mitochondrial DNA depletion in adipose tissue of HIV-infected patients with peripheral lipoatrophy.

Buffet M, Schwarzinger M, Amellal B, Gourlain K, Bui P, Prévot M, Deleuze J, Morini JP, Gorin I, Calvez V, Dupin N.

J Clin Virol. 2005 May;33(1):60-4.

PMID:
15797366
Items per page

Supplemental Content

Write to the Help Desk